School of Pharmacy, Shujitsu University , Okayama , Japan and.
Drug Metab Rev. 2015 May;47(2):89-110. doi: 10.3109/03602532.2015.1011658. Epub 2015 Feb 13.
This article reviews in vitro metabolic activities [including Michaelis constants (Km), maximal velocities (Vmax) and Vmax/Km] and drug-steroid interactions [such as induction and cooperativity (activation)] of cytochromes P450 (P450 or CYP) in human tissues, including liver and adrenal gland, for 14 kinds of endogenous steroid compounds, including allopregnanolone, cholesterol, cortisol, cortisone, dehydroepiandrosterone, estradiol, estrone, pregnenolone, progesterone, testosterone and bile acids (cholic acid). First, we considered the drug-metabolizing P450s. 6β-Hydroxylation of many steroids, including cortisol, cortisone, progesterone and testosterone, was catalyzed primarily by CYP3A4. CYP1A2 and CYP3A4, respectively, are likely the major hepatic enzymes responsible for 2-/4-hydroxylation and 16α-hydroxylation of estradiol and estrone, steroids that can contribute to breast cancer risk. In contrast, CYP1A1 and CYP1B1 predominantly metabolized estrone and estradiol to 2- and 4-catechol estrogens, which are endogenous ultimate carcinogens if formed in the breast. Some metabolic activities of CYP3A4, including dehydroepiandrosterone 7β-/16α-hydroxylation, estrone 2-hydroxylation and testosterone 6β-hydroxylation, were higher than those for polymorphically expressed CYP3A5. Next, we considered typical steroidogenic P450s. CYP17A1, CYP19A1 and CYP27A1 catalyzed steroid synthesis, including hydroxylation at 17α, 19 and 27 positions, respectively. However, it was difficult to predict which hepatic drug-metabolizing P450 or steroidogenic P450 will be mainly responsible for metabolizing each steroid hormone in vivo based on these results. Further research is required on the metabolism of steroid hormones by various P450s and on prediction of their relative contributions to in vivo metabolism. The findings collected here provide fundamental and useful information on the metabolism of steroid compounds.
这篇文章综述了人组织(包括肝和肾上腺)中 14 种内源性甾体化合物的细胞色素 P450(P450 或 CYP)的体外代谢活性(包括米氏常数(Km)、最大速度(Vmax)和 Vmax/Km)和药物-甾体相互作用(如诱导和协同作用(激活))。这些甾体化合物包括雄烷二醇、胆固醇、皮质醇、可的松、脱氢表雄酮、雌二醇、雌酮、孕烯醇酮、孕酮、睾酮和胆汁酸(胆酸)。首先,我们考虑了具有药物代谢作用的 P450。许多甾体化合物的 6β-羟化,包括皮质醇、可的松、孕酮和睾酮,主要由 CYP3A4 催化。CYP1A2 和 CYP3A4 分别可能是负责雌二醇和雌酮 2-/4-羟化和 16α-羟化的主要肝酶,这些甾体化合物可能导致乳腺癌风险。相比之下,CYP1A1 和 CYP1B1 主要代谢雌酮和雌二醇生成 2-和 4-儿茶酚雌激素,如果在乳腺中形成,这些雌激素是内源性最终致癌物质。CYP3A4 的一些代谢活性,包括脱氢表雄酮 7β-/16α-羟化、雌酮 2-羟化和睾酮 6β-羟化,高于多态性表达的 CYP3A5。接下来,我们考虑了典型的甾体生成 P450。CYP17A1、CYP19A1 和 CYP27A1 分别催化甾体的合成,包括在 17α、19 和 27 位的羟化。然而,根据这些结果,很难预测哪种肝药物代谢 P450 或甾体生成 P450 将主要负责体内代谢每种甾体激素。还需要对各种 P450 代谢甾体激素的情况以及对其在体内代谢的相对贡献进行预测。这里收集的研究结果为甾体化合物的代谢提供了基础和有用的信息。